For laboratory research use only. This page summarises published scientific literature on Peptide Bioavailability in plain English, in a neutral research style. It is not medical advice and contains no guidance on doses, administration or human use.
What Is Bioavailability and Why Does It Matter for Peptides?
Peptides are uniquely challenging from a bioavailability perspective because they face degradation at every stage: in the gastrointestinal tract (stomach acid + intestinal enzymes), during first-pass hepatic metabolism (for compounds absorbed from the gut), and in plasma (circulating proteases). Unlike lipophilic small molecules that can passively diffuse across membranes, most peptides are hydrophilic and too large to cross biological barriers without specific transport mechanisms.
Topical Application: Local vs. Systemic Effects
Topical application of peptides (creams, serums, patches) is extensively used in cosmetic research, particularly for GHK-Cu and synthetic collagen-stimulating peptides. The pharmacokinetics are fundamentally different from systemic routes:
Dermal penetration: The stratum corneum (outermost skin layer) is a significant barrier to peptide penetration. Small molecular weight peptides penetrate better than large ones; lipophilic modifications enhance penetration. GHK-Cu’s small size (MW ~340 Da) and positive charge facilitate some dermal penetration, though the fraction reaching deeper dermal fibroblasts is formulation-dependent.
Systemic bioavailability: Negligible for most topically applied peptides — the skin barrier prevents significant systemic absorption at cosmetic application levels. This is actually beneficial for safety (local action without systemic effects) but means topical peptides must reach their target cells (dermal fibroblasts) through the skin without entering systemic circulation in meaningful quantities.
Formulation importance: Penetration enhancers (dimethyl sulfoxide/DMSO, liposomes, nanoparticles, hyaluronic acid carrier systems) can dramatically improve topical peptide delivery into the dermis. Research comparing formulations is as important as the peptide itself for topical studies.
Bioavailability Modification Strategies in Research Peptides
PEGylation: Attaching polyethylene glycol chains increases molecular size (reducing renal filtration) and sterically protects peptide bonds from enzymatic attack. PEG-MGF is an example — PEGylation extends MGF’s plasma half-life from minutes to hours, dramatically changing its research pharmacokinetics.
Albumin binding (DAC): As in CJC-1295 with DAC — the Drug Affinity Complex binds to albumin in circulation, extending half-life to ~8 days by exploiting albumin’s long circulatory half-life as a slow-release reservoir.
D-amino acid substitution: Replacing L-amino acids with their D-enantiomers at protease-vulnerable positions confers resistance to enzymatic degradation. Several advanced research peptides use D-amino acids for this purpose.
Lipidation: Attaching fatty acid chains (as in clinical GLP-1 analogues like semaglutide) promotes albumin binding and extends circulating half-life from minutes (native GLP-1: ~2 minutes) to days (semaglutide: ~7 days).
Nanoparticle encapsulation: Encapsulating peptides in biodegradable nanoparticles or liposomes protects them during GI transit and can enable oral delivery for compounds that would otherwise be completely degraded. Active research area, though primarily in pharmaceutical development rather than existing research peptides.
Limits of the evidence
Published findings come from specific study designs, often in cell systems or animals, and do not transfer automatically to other settings. A paper about a molecule is not proof that any particular batch has a given biological effect. Purity data show what is in a vial; they do not show sterility, safety or suitability for any use outside the laboratory.
Laboratory handling
- Store lyophilised powder sealed, cold (−20 °C for long-term storage), dry and protected from light.
- Let vials reach room temperature before opening to limit condensation.
- Prepare solutions with suitable laboratory solvents and calibrated equipment, and label each with lot number, concentration and date.
- Split solutions into single-use aliquots and avoid repeated freeze–thaw cycles.
- Use the peptide calculator for concentration arithmetic (mg/mL).
For laboratory research use only. Peptide Bioavailability sold by Peptides Lab UK is supplied strictly for in vitro laboratory research. It is not for human or veterinary use, and nothing on this page is medical advice or guidance on administration. UK purchasers are responsible for complying with all applicable legislation.
